Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Phosphorus or phosphorus compound
Reexamination Certificate
2007-10-09
2007-10-09
Pak, John (Department: 1616)
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Phosphorus or phosphorus compound
C424S423000, C424S681000, C424S682000, C424S683000, C424S686000, C424S692000, C424S697000, C424S709000, C514S056000, C514S822000, C623S001430, C623S921000
Reexamination Certificate
active
10746048
ABSTRACT:
Treatment with magnesium produces a inhibition of acute stent thrombosis under high-shear flow conditions without any hemostatic or significant hemodynamic complications.
REFERENCES:
patent: 4182774 (1980-01-01), Welstead, Jr. et al.
patent: 5849338 (1998-12-01), Richardson et al.
patent: 6042849 (2000-03-01), Richardson et al.
patent: 6087373 (2000-07-01), Coburn et al.
patent: 6100297 (2000-08-01), Weglicki
patent: 6287332 (2001-09-01), Bolz et al.
patent: 6692772 (2004-02-01), Kaul et al.
patent: 6709379 (2004-03-01), Brandau et al.
patent: 2000210380 (2000-08-01), None
patent: PCT/GB00/00690 (2000-08-01), None
Carrozza, J.P. ‘Thrombosis and Drug-eluting stents: should we be concerned? A Commentary.’ [online]. Aug. 26, 2004, [retrieved on Apr. 28, 2006]. Retrieved from the Internet: <URL: http://www.cardiosource.com/ExpertOpinion/hottopics/article.asp?paperID=79 >.
‘Drug-Eluting Stents’. [online]. Apr. 3, 2006 [retrieved on Apr. 28, 2006]. Retrieved from the Internet: <URL: http://www.ptca.org/articles/desl.html >.
Somberg, J. et al., “Late stent thrombosis: problem or not?” The American Journal of Cardiology, vol. 99(7), Apr. 2007, pp. 1020-1023.
Hara, H. et al., “Role of stent design and coatings on restenosis and thrombosis,” Advanced Drug Delivery Reviews, vol. 58, pp. 377-386 (2006).
Medline abstract 2001681052 (2001).
Medline abstract 2002088281 (2002).
Medline abstract 2001408480 (2001).
Rukshin, V., et al., “Intravenous Magnesium in Experimental Stent Thrombosis in Swine,” Ateriorscler Thromb Vasc Biol. 21(9):1544-49 (Sep. 2001).
Gertz, D.S., et al., “Effect of Magnesium Sulfate on Thrombus Formation following Partial Arterial Constriction: Implications for Coronary Vasospasm,” Magnesium. 6(5):225-35 (1987).
Claus, H-D., “Zur Frage de Wirksamkeit einer thromboembolieprophylaxe durch Magnesium bei der Kontakttherapie von Portio- und Korpuskarzinomen der Uterus mit Gammastrahlem,” Strahlentherapie, 135(3):291-94 (Mar. 1968) (Abstract in English).
Ravn, H.B., et al., “Magnesium Inhibits Platelet Activity—Infusion Study in Healthy Volunteers,” Thrombosis and Haemostasis. 75(6):939-44 (Jun. 1996).
www.americanheart.org, Angioplasty, Percutaneous Transluminal Coronary (PTCA), Mar. 23, 2001.
H.B. Ravn, et al., “Early Administration of Intravenous Magnesium Inhibits Arterial Thrombus Formation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17(12), 1997, pp. 3620-3625.
Michael Shechter et al., “Low intracellular magnesium levels promote platelet-dependent thrombosis in patients with coronary artery disease,” American Heart Journal, 140:212-218 (Aug. 2000).
Vladimir Rukshin et al, “Intravenous Magnesium in Experimental Stent Thrombosis in Swine,” Arteriosclerosis, Thrombosis and Vascular Biology, 21:1544-1549 (Sep. 2001).
S.D. Gertz et al., “Effect of Magnesium Sulfate on Thrombus Formation Following Partial Arterial Constriction: Complications for Corornary Vasospasm,” Magnesium, vol. 6, No. 5, pp. 225-235 (1987).
H-D Claus, “Zur Frage der Wirksamkeit einer Thromboembolieprophylaxe durch Magnesium bei der Kontakttherapie von Portio- und Korpuskarzinomen der Uterus mit Gammastrahlern,” Strahlentherapie, vol. 135, No. 3, pp. 291-294 (1968).
H.B. Ravn et al., “Magnesium Inhibits Platelet Activity—an infusion study in healthy volunteers,” Thrombosis and Haemostasis, vol. 75, No. 6, pp. 939-944 (1996).
Vladimir Rukshin et al, “Comparative Antithrombotic Effects of Magnesium Sulfate and the Platelet Glycoprotein Ilb/Illa Inhibitors Tirofiban and Eptifibatide in a Canine Model of Stent Thrombosis,” Circulation, vol. 105, pp. 1970-1975 (2002).
Kaul Sanjay
Shah Prediman K.
Cedars-Sinai Medical Center
Davis , Wright, Tremaine, LLP
Levy Seth D.
Pak John
LandOfFree
Method of reducing thrombosis and complications after... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of reducing thrombosis and complications after..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of reducing thrombosis and complications after... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3863839